LHV finantsportaal

Foorum Investeerimine

Börsipäev 18. september

Kommentaari jätmiseks loo konto või logi sisse

  • Reedel sulgus Tallinna (-0.22%) indeks miinuses ning Riia (+0.37%) ja Vilnius (+0.20%) lõpetasid päeva plusspoolel. Käibeks kujunes põhinimekirjas 334 tehinguga 790 tuhat eurot, millest Tallinna börsi käive moodustas 194 tehinguga 434 tuhat eurot ja Vilniuse börsi käive 123 tehinguga 338 tuhat eurot.

    Enimkaubeldud aktsia oli Šiaulių bankas (-0.35%) – käive 238 tuhat eurot ja tehingute arv 27, mille hulgas oli ka kaks plokktehingut (EUR 0.568 x 100000, EUR 0.568 x 82555). Olympic Entertainment Group (+2.20%) aktsiaga tehti 67 tehingut kogumahus 185 tuhat eurot. Tallink Grupp (-2.75%) käive 182 tuhat eurot moodustati 57 tehinguga.

    Suurimad tõusjad olid Klaipėdos nafta (+4.04%, käive EUR 10k), Arco Vara (+3.38%, käive EUR 6k), Panevėžio statybos trestas (+2.86%, käive EUR 7k). Enim langesid PRFoods (-3.88%, käive EUR 5k), Tallink Grupp (-2.75%, käive EUR 182k), Baltika (-2.04%, käive EUR 1k).

    Täna toimub Skano Group aktsionäride erakorraline üldkoosolek
    19.09 Latvijas kuģniecība aktsionäride erakorraline üldkoosolek
    22.09 Rokiškio sūris aktsionäride erakorraline üldkoosolek

    Eelmise nädala hinnamuutused:
  • On üsna haruldane näha Ühendriikides aktsiaturgu tegemas septembris uusi tippe, ent just sellega saadi reedel hakkama, kui S&P 500 indeks kerkis 0,2% 2500,2 punktini. Olgugi et Põhja-Korea lennutas järjekordse raketi üle Jaapani ning makromajanduslikud näitajad jäid reedel oodatust nõrgemaks, otsustati seda ignoreerida ning kasutada ära tugevat momentumit, mis viis S&P 500 nädala lõikes 1,6% (eurodes 1,7%) kõrgemale. Euroopas tiksus Stoxx 600 reedel -0,3% madalamale, lõpetades viie tööpäeva peale siiski 1,4% plussis.



    USA augustikuu jaemüüki oodates eeldati, et orkaan Harvey jätab tõenäoliselt oma jälje mitmel tasandil, alates tõusnud kütusehinnast ja lõpetades müügipäevade arvu vähendamisega. Jättes välja nii automüügi kui ka kütuse, osutus jaemüük arvatust isegi nõrgemaks, kahanedes MoM -0,1% prognoositud 0,3% kasvu asemel. Arvestades jaemüügi kõrval veel tööstustoodangu statistikat, mis osaliselt orkaani tõttu alanes augustis MoM -0,9% (oodati +0,1%), olid analüüsimajad sunnitud tooma USA kolmanda kvartali SKP ootust allapoole. Muuhulgas korrigeeris oma ootust madalamaks ka Atlanta FED, kes näeb nüüd majandust kasvamas 3,0% asemel 2,2%.



    Hiina kinnisvaraturu augustikuu statistikast on näha, et valitsuse jahutavad meetmed ning pakkumise suurendamine on suurlinnades endiselt mõju avaldamas, vähendades keskmist hinnakasvu 4,8%ni juulikuu 8,4% pealt. Samuti on näha, et hinnamõju kandub tugevamalt üle ka keskmise ja väiksema suurusega linnadesse, kus hinnakasv oli augustis vastavalt 8,4% ja 8,2% (juulis 10,0% ja 8,4%).



    Nädal algab tagasihoidliku majandusuudiste valikuga, kuid kogub tuure järgnevatel päevadel, mil fookuses saab ennekõike olema FOMC järjekordne istung, mille raames peaks selguma bilansi vähendamise algus.

    12.00 Eurotsooni inflatsioon (augusti lõplik)
    17.00 USA majade ehitajate kindlustunde indeks (september)
  • ECB'S HANSSON IN REUTERS INTERVIEW SAYS BANK'S NEXT MOVE SHOULD BE BROADER RECALIBRATION OF STIMULUS, NOT JUST CHANGE IN QE LENGTH, VOLUME
    ECB'S HANSSON SAYS ECB STEPS COULD INVOLVE NEW REFINANCING OPS, REWORKED GUIDANCE, MORE DETAIL ON REINVESTMENTS
    ECB'S HANSSON: ECB SHOULD DISCUSS MAKING GUIDANCE SYMMETRIC, STANDING READY TO BOTH INCREASE OR DECREASE ASSET BUYS IF NEEDED
    ECB'S HANSSON: NORMALISATION SHOULD BE GRADUAL BUT BANK SHOULD NOT SEEK TO ERR ON SIDE OF CAUTION

  • Gapping up
    In reaction to strong earnings/guidance:

    HUN +1.9%, (expects 'strong' Q3 results, after excluding the Pigments and Additives division, which will now be reported in discontinued operations)
    M&A news:
    SSNI +24.6% (to be acquired by Itron (ITRI) for $16.25/share)
    OA +19.8% (confirms deal to be acquired by Northrop Grumman (NOC) in a $9.2 bln deal)
    RAD +4.2% (Walgreens Boot Alliance said to plan to revise its pending agreement to acquire Rite-Aid (RAD) stores in effort to gain regulatory approval for the proposed deal, according to Bloomberg)
    UPL +2.3% (largest stockholder Firm Tree Partners announces its intention to immediately engage with Co management to pursue value-maximizing strategic alternatives)
    Select China related names showing strength:
    MOMO +1.1%, WB +1%, JD +0.8%, BIDU +0.7%
    Other news:
    NBRV +101.2% (announces 'positive' results from the lefamulin evaluation against pneumonia trial)
    PSTI +17.9% (FDA has granted Fast Track Designation to the co's ongoing Phase III study of PLX-PAD cells for the treatment of Critical Limb Ischemia in patients ineligible for revascularization)
    PTIE +14.4% (receives an approx. $1.8 mln research grant from the NIH and $2.2 mln grant from the National Institute on Drug Abuse)
    BLDP +5.4% (received a purchase order from Nisshinbo Holdings)
    SNGX +3.3% (receives from the NCI a two-year, approx. $1.5 mln SBIR grant to support its Phase 3 study evaluating SGX301)
    NLNK +2.6% (modestly rebounding following last weeks 28% loss)
    KTOS +2.3% (S&P upgraded Kratos Defense & Security Solutions Inc. to 'B' on expected debt repayment, outlook positive)
    TRXC +2% (responds to the FDA's Additional Info request related to its Senhance Surgical Robotic System 510(k) submission; continues to expect 510(k) clearance in 2017), TNXP +1.9% (files to withdraw registration statement on Form S-3 filed on Aug 11)
    MRTX +1.8% (continued strength)
    RDHL +1.6% (receives a NOA from the USPTO for a new patent covering the use of two of YELIVA and MUSPRON in combination with a known antibiotic)
    NOK +1.1% (receives decision in patent license arbitration with LG Electronics (LGEAF); expects that revenue for the agreement will be recognized in Q3)
    LB +0.9% (authorizes $250 mln share repurchase program)
    Analyst comments:
    ARWR +8.5% (upgraded to Outperform from Mkt Perform at William Blair)
    PAH +3% (upgraded to Buy from Hold at SunTrust)
    NVDA +2.1% (target raised to $210 from $185 at BofA/Merrill )
    YUMC +1.7% (upgraded to at )
    CAT +1.6% (upgraded to Buy from Neutral at UBS)
    INST +1.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
    AMAT +1.4% (upgraded to Outperform at RBC Capital Mkts)
    ASML +1.2% (upgraded to Positive from Neutral at Susquehanna)
    CMPR +1% (upgraded to Outperform from Mkt Perform at Barrington Research)
    SONC +0.8% (initiated with a Buy at Citigroup)
    Gapping down
    In reaction to disappointing earnings/guidance:

    STNG -5.7%
    Select metals/mining stocks trading lower:
    HMY -4.7%, GFI -1.8%, AUY -1.4%, GOLD -1.1%, GDX -0.8%, NEM -0.8%, GLD -0.7%
    Other news:
    HMNY -13.6% (files for approx 9.1 mln share common stock offering by holders)
    TISI -5.9% (CEO steps down)
    FRED -3.1% (amends short-term shareholder rights plan to protect the ability to utilize net operating losses)
    CLDR -2.1% (files $175 mln mixed securities shelf offering)
    RYAAY -1.8% (after acknowledging that a scheduling mix up will force it to cancel hundreds of flights over the coming weeks), .
    Analyst comments:
    BRKS -4.3% (downgraded to Hold from Buy at Needham)
    CRUS -2% (initiated with a Underperform at BofA/Merrill)

    Briefing.com

Teemade nimekirja